Trial Profile
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Methoxamine (Primary)
- Indications Faecal incontinence
- Focus Therapeutic Use
- Acronyms Libertas
- Sponsors Norgine
- 08 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 21 May 2014 New trial record